4FO Ventures

4FOX Ventures operates as a venture capital firm specializing in early-stage investments. It targets Swiss healthcare and technology companies with global aspirations, focusing on fostering sustainable international leaders. The firm employs a hands-on approach, providing operational and investment expertise to entrepreneurs across various development stages, aiming to create enduring value within its portfolio.

The firm was launched in 2017 under the leadership of Jean-Pierre Rosat and Andre Hoffmann. Jean-Pierre Rosat's extensive background in life sciences and medical technology ventures, including roles at Aleva Neurotherapeutics and Cytion, provided a foundational insight into the specific capital and strategic support needed by emerging companies in these sectors. This expertise shapes 4FOX Ventures' entrepreneur-centric investment philosophy.

4FOX Ventures serves founders and their early-stage companies, offering strategic partnership and guidance beyond mere financial contributions. Its long-term vision centers on cultivating positive environmental, social, and governance impacts across its portfolio. The firm aims to empower innovative ventures to scale internationally, thereby contributing to a sustainable future through technological and healthcare advancements.